Citadel Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Buy
185,393
+32,782
+21% +$573K ﹤0.01% 5302
2025
Q4
$2.71M Buy
152,611
+141,386
+1,260% +$2.48M ﹤0.01% 5356
2025
Q3
$208K Sell
11,225
-33,131
-75% -$682K ﹤0.01% 11185
2025
Q2
$953K Buy
44,356
+30,380
+217% +$657K ﹤0.01% 7212
2025
Q1
$344K Sell
13,976
-42,262
-75% -$1.04M ﹤0.01% 9277
2024
Q4
$1.3M Buy
56,238
+6,137
+12% +$153K ﹤0.01% 6502
2024
Q3
$1.36M Buy
50,101
+8,270
+20% +$251K ﹤0.01% 6239
2024
Q2
$1.2M Sell
41,831
-68,336
-62% -$2.09M ﹤0.01% 6238
2024
Q1
$3.21M Buy
110,167
+48,997
+80% +$1.37M ﹤0.01% 4660
2023
Q4
$1.99M Buy
61,170
+7,350
+14% +$213K ﹤0.01% 5360
2023
Q3
$1.72M Buy
53,820
+46,904
+678% +$1.81M ﹤0.01% 5497
2023
Q2
$303K Buy
6,916
+1,767
+34% +$81.5K ﹤0.01% 9027
2023
Q1
$228K Sell
5,149
-42,445
-89% -$1.88M ﹤0.01% 9943
2022
Q4
$1.89M Buy
47,594
+3,778
+9% +$157K ﹤0.01% 5595
2022
Q3
$2.02M Buy
+43,816
New +$2.15M ﹤0.01% 5561
2022
Q2
Sell
-35,421
Closed -$1.91M 13521
2022
Q1
$1.91M Buy
35,421
+12,381
+54% +$633K ﹤0.01% 6182
2021
Q4
$1.38M Sell
23,040
-19,821
-46% -$1.23M ﹤0.01% 7083
2021
Q3
$2.81M Buy
42,861
+3,234
+8% +$210K ﹤0.01% 5528
2021
Q2
$2.5M Buy
+39,627
New +$2.28M ﹤0.01% 6042
2021
Q1
Sell
-140,561
Closed -$6.75M 13482
2020
Q4
$5.8M Buy
140,561
+83,321
+146% +$3.82M ﹤0.01% 3431
2020
Q3
$2.63M Buy
57,240
+16,875
+42% +$783K ﹤0.01% 4219
2020
Q2
$1.77M Buy
40,365
+15,710
+64% +$707K ﹤0.01% 4803
2020
Q1
$977K Sell
24,655
-4,098
-14% -$184K ﹤0.01% 5375
2019
Q4
$1.35M Buy
28,753
+2,125
+8% +$82.3K ﹤0.01% 5053
2019
Q3
$939K Buy
26,628
+4,573
+21% +$158K ﹤0.01% 5705
2019
Q2
$860K Buy
22,055
+10,848
+97% +$437K ﹤0.01% 5939
2019
Q1
$495K Buy
+11,207
New +$426K ﹤0.01% 6797

Other funds holding KIDS

Citadel Advisors's KIDS Position: Q1 2026 in Review

Citadel Advisors increased its OrthoPediatrics (KIDS) stake by 21% in Q1 2026, buying an estimated $573K and bringing the position to 185,393 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #5302.

Citadel Advisors first reported a position in KIDS in Q1 2019 and has held it in 27 quarters since. The position peaked at $5.8M in Q4 2020. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Citadel Advisors held 185,393 shares of OrthoPediatrics worth $2.94M as of Q1 2026.
  • Citadel Advisors bought 32,782 OrthoPediatrics shares in Q1 2026, an estimated $573K.
  • OrthoPediatrics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5302 holding.
  • Citadel Advisors first reported a position in OrthoPediatrics in Q1 2019 and has held it in 27 quarters since.
  • Citadel Advisors's OrthoPediatrics position peaked at $5.8M in Q4 2020.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.